Elaboration of thorough simplified vinca alkaloids as antimitotic agents based on pharmacophore similarity. 2013

Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, PR China.

Thorough simplification of vinca alkaloids based on pharmacophore similarity has been conducted. A concise process for the syntheses of target compounds was successfully developed with yields from poor to excellent (19-98%). Cell growth inhibitory activities of these synthesized compounds were evaluated in five cancer cell lines including MCF-7, MDA-MB-231, HepG2, HepG2/ADM and K562. Almost all compounds exhibited moderate antitumor activity with optimal IC50 value of 0.89 ± 0.07 μM in MCF-7 cells. Investigation of structure-activity relationship (SAR) indicates that electron-withdraw substituents on the ring contribute to the enhancement of the antitumor activities. The simplified vinca alkaloids are confirmed as antimitotic agents, which inhibit the polymerization of tubulin just like vinblastine.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014748 Vinca Alkaloids A group of indole-indoline dimers which are ALKALOIDS obtained from the VINCA genus of plants. They inhibit polymerization of TUBULIN into MICROTUBULES thus blocking spindle formation and arresting cells in METAPHASE. They are some of the most useful ANTINEOPLASTIC AGENTS. Alkaloids, Vinca
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
March 2010, Chemical biology & drug design,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
March 2012, Anti-cancer agents in medicinal chemistry,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
October 1991, Fortschritte der Medizin,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
September 2018, Bioorganic & medicinal chemistry letters,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
September 1963, Cancer research,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
December 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
January 2015, The journal of physical chemistry. B,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
January 2005, Current pharmaceutical design,
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
January 2019, Cancer drug resistance (Alhambra, Calif.),
Jing Zheng, and Lijuan Deng, and Minfeng Chen, and Xuzhi Xiao, and Shengwei Xiao, and Cuiping Guo, and Gaokeng Xiao, and Liangliang Bai, and Wencai Ye, and Dongmei Zhang, and Heru Chen
January 2014, Current topics in medicinal chemistry,
Copied contents to your clipboard!